SCHEMBL23055119

SCHEMBL23055119

CCc1ccccc1C(CC)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HTT P42858 3/20 0.40
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
CNR2 P34972 1/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6546270 0.87 HTR2A (0.45) HTTMEN1KMT2ALMNATSHR
SCHEMBL23055121 0.82 AGBL2 (0.38) ALDH1A1MAPK1MEN1KMT2ALMNA
SCHEMBL25482210 0.82 ALDH1A1 (0.43) ALDH1A1HTTKDM4ESMN1; SMN2MAPK1
SCHEMBL30910943 0.81 ALDH1A1 (0.42) ALDH1A1HTTKDM4ESMN1; SMN2MEN1
SCHEMBL21831295 0.81 ALDH1A1 (0.42) ALDH1A1HTTKDM4ESMN1; SMN2MEN1
SCHEMBL17802355 0.81 LMNA (0.46) ALDH1A1HTTKDM4EMEN1KMT2A
SCHEMBL360080 0.81 LMNA (0.46) ALDH1A1HTTKDM4EMEN1KMT2A
Ammonia Solution, Strong SCHEMBL6001428 0.80 HTT (0.40) ALDH1A1HTTKDM4ESMN1; SMN2MAPK1
SCHEMBL21910188 0.79 ALDH1A1 (0.41) ALDH1A1HTTKDM4ESMN1; SMN2MEN1
SCHEMBL23003618 0.79 TSHR (0.53) ALDH1A1KDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584747-B2 Substituted pyridopyrimidinonyl compounds useful as T cell activators SYNGENE INTERNATIONAL LIMITED (IN) 2023-02-21 US disclosed
US-20210061802-A1 SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS SYNGENE INTERNATIONAL LIMITED (IN) 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584747-B2 Substituted pyridopyrimidinonyl compounds useful as T cell activators DGKZ, DGKA, DGKG ALDH1A1 4233/4885HTT 4810/4885KDM4E 1828/4885
US-20210061802-A1 SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS DGKZ, DGKA, DGKG ALDH1A1 4233/4885HTT 4810/4885KDM4E 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.